EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Effects of malaria intermittent preventive treatment with dihydroartemisinin-piperaquine on antiretroviral drug concentrations in African pregnant women living with HIV

Linda Stöger iD, Johannes Mischlinger iD, Tacilta Nhampossa iD, Ghyslain Mombo-Ngoma iD, Meral Esen iD, André-Marie Tchouatieu iD, Mercè Brunet iD, Anete Mendes iD, Lia Betty Dimessa Mbadinga, Sara Gamberini, Wilfrid Ndzebe Ndoumba iD, Antía Figueroa-Romero iD und 16 weitere

Antimicrobial Agents and Chemotherapy · 01.07.2026 · 70 (7)

DOI: 10.1128/aac.00337-26 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, erschienen am 01.07.2026. Verfasst von Linda Stöger und 27 weiteren Autor:innen. Beteiligte Einrichtung: ISGlobal, Barcelona, Spain. Hauptthemen laut MEDLINE: Artemisinins, Quinolines, Antimalarials, HIV Infections. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European and Developing Countries Clinical Trials Partnership, Medicines for Malaria Venture.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Intermittent preventive treatment during pregnancy (IPTp) for malaria prevention with sulfadoxine-pyrimethamine is contraindicated in pregnant women living with HIV receiving cotrimoxazole prophylaxis. A recent clinical trial showed that dihydroartemisinin-piperaquine (DHA-PPQ) for IPTp is a safe and effective option for malaria prevention in this population. The present study evaluated the impact of monthly IPTp with DHA-PPQ on antiretroviral (ARV) drug concentrations in 105 participants recruited in the aforementioned trial in Mozambique and Gabon between January and November 2021. ARV serum concentrations from maternal venous and cord blood collected at the first antenatal care visit and at the end of pregnancy were measured by ultra-high-performance liquid chromatography-tandem mass spectrometry. At the end of pregnancy, median concentrations of dolutegravir were 835.1 ng/mL (248.1–1,687.6) in maternal and 1,204.2 ng/mL (456.4–1,883.3) in cord blood. For lamivudine (3TC), median concentrations were 108.3 ng/mL (28.8–246.1) in maternal and 186.5 ng/mL (81.9–427.6) in cord blood. No significant differences in ARV concentrations were found between the antimalarial treatment arm and the placebo arm. Furthermore, in multivariate exploratory analysis, no independent associations were found between ARV concentrations and participant characteristics. Our study found similar ARV concentrations in both treatment groups, suggesting that DHA-PPQ for monthly IPTp does not affect ARV concentrations in maternal and cord blood in women living with HIV. CLINICAL TRIALS This study is registered with ClinicalTrials.gov as NCT03671109 .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ArtemisininsQuinolinesAntimalarialsHIV InfectionsMalariaAnti-Retroviral AgentsAnti-HIV AgentsHumansFemalePregnancyPiperazinesAdultDrug CombinationsYoung Adult

Stichwörter der Autor:innen

HIVantiretroviral therapydihydroartemisinin-piperaquinemalariapregnancy

Substanzen

artenimolArtemisininsQuinolinespiperaquinePiperazinesAntimalarialsDrug CombinationsAnti-Retroviral AgentsAnti-HIV Agents

Autor:innen und Institutionen

  • ISGlobal, Barcelona, Spain.
  • Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona (UB), Barcelona, Spain.
  • Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública, Instituto de Salud Carlos III, Madrid, Spain.
  • Center for Tropical Medicine, Bernhard Nocht Institute for Tropical Medicine & I Dept. of Medicine University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • German Center for Infection Research, partner site Hamburg-Lübeck-Borstel-Riems, Tübingen, Germany.
  • Centro de Investigação em Saúde de Manhiça (CISM), Manhiça, Mozambique.

ORCID-Profile: Linda Stöger, Johannes Mischlinger, Tacilta Nhampossa, Ghyslain Mombo-Ngoma, Meral Esen, André-Marie Tchouatieu, Mercè Brunet, Anete Mendes, Wilfrid Ndzebe Ndoumba, Antía Figueroa-Romero, Bertrand Lell, Heimo Lagler, Rella Zoleko-Manego, Myriam El Gaaloul, Susana Méndez, Núria Botella, Sergi Sanz, Esperança Sevene, Francisco Saúte, Sebastian G Wicha, Dolors Soy, Clara Menéndez, Michael Ramharter, Raquel González

Förderung

  • European and Developing Countries Clinical Trials Partnership
  • Medicines for Malaria Venture

Zitieren

APA

Stöger, L., Mischlinger, J., Nhampossa, T., Mombo-Ngoma, G., Esen, M., Tchouatieu, A. M., Brunet, M., Mendes, A., Dimessa Mbadinga, L. B., Gamberini, S., Ndzebe Ndoumba, W., Figueroa-Romero, A., Lell, B., Lagler, H., Zoleko-Manego, R., El Gaaloul, M., Méndez, S., Botella, N., Sanz, S., …, & MAMAH Study Group (2026). Effects of malaria intermittent preventive treatment with dihydroartemisinin-piperaquine on antiretroviral drug concentrations in African pregnant women living with HIV. Antimicrobial Agents and Chemotherapy, 70(7). https://doi.org/10.1128/aac.00337-26

Vancouver

Stöger L, Mischlinger J, Nhampossa T, Mombo-Ngoma G, Esen M, Tchouatieu AM, et al. Effects of malaria intermittent preventive treatment with dihydroartemisinin-piperaquine on antiretroviral drug concentrations in African pregnant women living with HIV. Antimicrobial Agents and Chemotherapy. 2026;70(7). doi:10.1128/aac.00337-26

BibTeX
@article{Stger2026,
  author = {Stöger, Linda and Mischlinger, Johannes and Nhampossa, Tacilta and Mombo-Ngoma, Ghyslain and Esen, Meral and Tchouatieu, André-Marie and Brunet, Mercè and Mendes, Anete and Dimessa Mbadinga, Lia Betty and Gamberini, Sara and Ndzebe Ndoumba, Wilfrid and Figueroa-Romero, Antía and Lell, Bertrand and Lagler, Heimo and Zoleko-Manego, Rella and El Gaaloul, Myriam and Méndez, Susana and Botella, Núria and Sanz, Sergi and Piqueras, Mireia and Sevene, Esperança and Saúte, Francisco and Wicha, Sebastian G and Soy, Dolors and Menéndez, Clara and Ramharter, Michael and González, Raquel and MAMAH Study Group, MAMAH Study Group},
  title = {Effects of malaria intermittent preventive treatment with dihydroartemisinin-piperaquine on antiretroviral drug concentrations in African pregnant women living with HIV},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2026},
  volume = {70},
  number = {7},
  doi = {10.1128/aac.00337-26}
}
Kostenlos starten →